Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2022;28(4):929-930. Published online September 8, 2022

DOI: https://doi.org/10.3350/cmh.2022.0260

View: 1286 Download: 45 Citation: 1

Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung

Clin Mol Hepatol. 2022;28(4):926-928. Published online September 5, 2022

DOI: https://doi.org/10.3350/cmh.2022.0233

View: 1340 Download: 49 Citations: 2

Markus Wilhelmi

Clin Mol Hepatol. 2021;27(2):360-361. Published online March 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0088

View: 2507 Download: 96

Sook-Hyang Jeong

Clin Mol Hepatol. 2018;24(1):10-19. Published online January 5, 2018

DOI: https://doi.org/10.3350/cmh.2017.0066

View: 9037 Download: 272 Citations: 13

1 |

Viewed By 4109	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 2677	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2432	The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Viewed By 2405	Recent updates on the management of autoimmune hepatitis
Viewed By 2401	Management of refractory ascites

Cited By 99	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 42	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 42	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 40	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 38	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search